Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company that manufactures and supplies generic pharmaceutical products. The company's product portfolio includes oral solids, oncology OSD, general and oncology injectables, generic formulations, and ophthalmic and dermatology products. It offers products for therapeutic areas of cardiovascular, analgesics, gynecology, cough and cold, gastroenterology, ophthalmology, anti-diabetics, orthopedic, urology and dermatological therapies. The company operates India, the US, Canada, Brazil, Australia and South Africa. APL is headquartered in Vadodara, Gujarat, India.
Headquarters
India
Address
Alembic Road, Vadodara, Gujarat, 390003
Website
www.alembicpharmaceuticals.com
Telephone
91 265 6637000
No of Employees
14,593
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
APLLTD (NSE)
Revenue (2022)
$720.4M
6.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-34.4%
(2022 vs 2021)
Market Cap*
$2.3B
Net Profit Margin (2022)
XYZ
-38.4%
(2022 vs 2021)
* As of and is in US$
Alembic Pharmaceuticals Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Oral Solids | Veldrop |
| Oncology OSD | Veldrop Gel |
| General and Oncology Injectables | Omegared |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Regulatory Approval | In April, the company secured approval from the US Food and Drug Administration for Ribociclib Tablets. |
| 2023 | Regulatory Approval | In March, the company received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Brimonidine Tartrate Ophthalmic Solution. |
| 2023 | Regulatory Approval | In March, the company received final approval from the US Food & Drug Administration for its abbreviated new drug application Fluorouracil Injection USP. |
Competitor Comparison
| Key Parameters | Alembic Pharmaceuticals Ltd | Aurobindo Pharma Ltd | Laurus Labs Ltd | Gland Pharma Ltd | Aarti Drugs Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Vadodara | Hyderabad | Hyderabad | Hyderabad | Mumbai |
| State/Province | Gujarat | Telangana | Telangana | Telangana | Maharashtra |
| No. of Employees | 14,593 | 15,690 | 5,753 | 4,585 | 1,500 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Chirayu Ramanbhai Amin | Chairman; Chief Executive Officer | Executive Board | 2010 | - |
| Raj Kumar Baheti | Chief Financial Officer; Director - Finance | Executive Board | - | - |
| Pranav Chirayu Amin | Managing Director | Executive Board | 2016 | - |
| Shaunak Chirayu Amin | Managing Director | Executive Board | 2013 | - |
| Namita Patwari | Chief Human Resources Officer | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward